8
Feb
2016
Why Patents Are Sometimes Overrated
You could get the impression, reading about the patent fight over the CRISPR-Cas9 genome editing, that patents are the only thing that matter in biotech. Once the courts sort out who the rightful inventors are, that’s that. The winner gets fame and fortune. Losers get a set of steak knives, or fired. All or nothing. This is a reasonable view... Read More